A Study of Romosozumab in People With Breast Cancer and Osteoporosis
Clinical trial NCT07776613 · RECRUITING
Trial details
- NCT number
- NCT07776613
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-17
- Primary completion
- 2028-08-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.